FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kenneth Ugen

Research Profile

Living Beings

HIV-1
Mouse

Chemicals & Drugs

Procedures

Anatomy

Co-author Network

Publications

TOP 3
W G Marshall; B A Boone; J D Burgos; S I Gografe; M K Baldwin; M L Danielson; M J Larson; D R Caretto; Y Cruz; B Ferraro; Loree C Heller; Kenneth Ugen; Mark J Jaroszeski; Richard Heller
Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression.
Michele A Kutzler; K A Kraynyak; S J Nagle; Rose Parkinson; D Zharikova; Michael Chattergoon; H Maguire; K Muthumani; Kenneth Ugen; David B Weiner
Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo.
Karuppiah Muthumani; Vance M Lambert; Niranjan Y Sardesai; Jong J Kim; Richard Heller; David B Weiner; Kenneth Ugen
Analysis of the potential for HIV-1 Vpr as an anti-cancer agent.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kenneth Ugen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: W G Marshall; B A Boone; J D Burgos; S I Gografe; M K Baldwin; M L Danielson; M J Larson; D R Caretto; Y Cruz; B Ferraro; Loree C Heller; Kenneth Ugen; Mark J Jaroszeski; Richard Heller
Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression.
Gene therapy 2010;17(3):419-23.
2010: Michele A Kutzler; K A Kraynyak; S J Nagle; Rose Parkinson; D Zharikova; Michael Chattergoon; H Maguire; K Muthumani; Kenneth Ugen; David B Weiner
Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo.
Gene therapy 2010;17(1):72-82.
2009: Karuppiah Muthumani; Vance M Lambert; Niranjan Y Sardesai; Jong J Kim; Richard Heller; David B Weiner; Kenneth Ugen
Analysis of the potential for HIV-1 Vpr as an anti-cancer agent.
Current HIV research 2009;7(2):144-52.
2009: Karuppiah Muthumani; Vance M Lambert; Mayilvahanan Shanmugam; Khanh P Thieu; Andrew Y Choo; J Christopher W Chung; Abhishek Satishchandran; J Joseph Kim; David B Weiner; Kenneth Ugen
Anti-tumor activity mediated by protein and peptide transduction of HIV viral protein R (Vpr).
Cancer biology & therapy 2009;8(2):180-7.
2008: Adil I Daud; Ronald C DeConti; Stephanie Andrews; Patricia Urbas; Adam I Riker; vernon sondak; Pamela N Munster; Daniel M Sullivan; Kenneth Ugen; Jane L Messina; Richard Heller
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(36):5896-903.
2008: R S Solórzano-Vargas; Vitaly Vasilevko; Gonzalo Acero; Kenneth Ugen; R Martinez; Tzipe Govezensky; R Vazquez-Ramirez; C Kubli-Garfias; David H Cribbs; Karen Manoutcharian; Goar Gevorkian
Epitope mapping and neuroprotective properties of a human single chain FV antibody that binds an internal epitope of amyloid-beta 1-42.
Molecular immunology 2008;45(4):881-6.
2008: Milan Fiala; Elyse J Singer; Deborah Commins; Tamara Mirzapoiazova; Alexander Dmitriyevich Verin; Araceli Espinosa; Kenneth Ugen; Michael Bernas; Marlys H Witte; Martin Weinand; Albert S Lossinsky
HIV-1 Antigens in Neurons of Cocaine-Abusing Patients.
The open virology journal 2008;2():24-31.
2007: Andrea N McCray; Kenneth Ugen; Richard Heller
Enhancement of anti-melanoma activity of a plasmid expressing HIV-1 Vpr delivered through in vivo electroporation.
Cancer biology & therapy 2007;6(8):1269-75.
2007: Qingyou Li; Marcia N Gordon; Chuanhai Cao; Kenneth Ugen; Dave Morgan
Improvement of a low pH antigen-antibody dissociation procedure for ELISA measurement of circulating anti-Abeta antibodies.
BMC neuroscience 2007;8():22.
2006: Kenneth Ugen; Susan B Nyland
Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.
Springer seminars in immunopathology 2006;28(3):281-7.
2006: Andrea N McCray; Kenneth Ugen; Karuppiah Muthumani; J J Kim; David B Weiner; Richard Heller
Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;14(5):647-55.
2006: Kenneth Ugen; Michele A Kutzler; B Marrero; J Westover; Domenico Coppola; David B Weiner; Richard Heller
Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation.
Cancer gene therapy 2006;13(10):969-74.
2006: Michele A Kutzler; Chuanhai Cao; Yun Bai; Huiqin Dong; Philip Y Choe; Vera Saulino; Laura McLaughlin; Alex Whelan; Andrew Y Choo; David B Weiner; Kenneth Ugen
Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice.
Vaccine 2006;24(21):4630-9.
2005: Rob Roy MacGregor; Jean D Boyer; Kenneth Ugen; Pablo Tebas; Terry J Higgins; Yaela Baine; Richard B Ciccarelli; Richard S Ginsberg; David B Weiner
Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral "blips".
Vaccine 2005;23(17-18):2066-73.
2005: Loree C Heller; Kenneth Ugen; Richard Heller
Electroporation for targeted gene transfer.
Expert opinion on drug delivery 2005;2(2):255-68.
2004: Chuanhai Cao; Yun Bai; Mary Jolene Holloway; Rebecca L Edgeworth; Eugene A Jackson; Joseph Cotropia; Kenneth Ugen
Characterization of a novel human anti-HIV-1 gp41 IgM monoclonal antibody designated clone 37.
DNA and cell biology 2004;23(12):836-41.
2004: Karuppiah Muthumani; Andrew Y Choo; Daniel S Hwang; Kenneth Ugen; David B Weiner
HIV-1 Vpr: enhancing sensitivity of tumors to apoptosis.
Current drug delivery 2004;1(4):335-44.
2004: Karen Manoutcharian; Gonzalo Acero; Maria Elena Munguia; Baltazar Becerril; L Massieu; Tzipe Govezensky; E Ortiz; J D Marks; Chuanhai Cao; Kenneth Ugen; Goar Gevorkian
Human single chain Fv antibodies and a complementarity determining region-derived peptide binding to amyloid-beta 1-42.
Neurobiology of disease 2004;17(1):114-21.
2004: Qingyou Li; Chuanhai Cao; Bryce Chackerian; John Schiller; Marcia N Gordon; Kenneth Ugen; Dave Morgan
Overcoming antigen masking of anti-amyloidbeta antibodies reveals breaking of B cell tolerance by virus-like particles in amyloidbeta immunized amyloid precursor protein transgenic mice.
BMC neuroscience 2004;5():21.
2004: Malavika Giri; Kenneth Ugen; David B Weiner
DNA vaccines against human immunodeficiency virus type 1 in the past decade.
Clinical microbiology reviews 2004;17(2):370-89.
2004: Donna Wilcock; Sanjay K Munireddy; Arnon Rosenthal; Kenneth Ugen; Marcia N Gordon; Dave Morgan
Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration.
Neurobiology of disease 2004;15(1):11-20.
2004: Flavia Ferrantelli; Moiz Kitabwalla; Robert A Rasmussen; Chuanhai Cao; Ting-Chao Chou; Hermann Katinger; Gabriela Stiegler; Lisa A Cavacini; Yun Bai; Joseph Cotropia; Kenneth Ugen; Ruth Ruprecht
Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine.
The Journal of infectious diseases 2004;189(1):71-4.
2003: Kenneth Ugen; Richard Heller
Electroporation as a method for the efficient in vivo delivery of therapeutic genes.
DNA and cell biology 2003;22(12):753.
2003: Karen Manoutcharian; Gonzalo Acero; Maria Elena Munguia; J A Montero; Tzipe Govezensky; Chuanhai Cao; Kenneth Ugen; Goar Gevorkian
Amyloid-beta peptide-specific single chain Fv antibodies isolated from an immune phage display library.
Journal of neuroimmunology 2003;145(1-2):12-7.
2003: L Austin; Gary W Arendash; Marcia N Gordon; David M Diamond; Giovanni DiCarlo; Chad A Dickey; Kenneth Ugen; Dave Morgan
Short-term beta-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP + PS1 mice.
Behavioral neuroscience 2003;117(3):478-84.
2003: Donna Wilcock; Giovanni DiCarlo; Debbi Henderson; Jennifer Jackson; Keisha Clarke; Kenneth Ugen; Marcia N Gordon; Dave Morgan
Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(9):3745-51.
2003: Susan B Nyland; Chuanhai Cao; Yun Bai; Thomas P Loughran; Kenneth Ugen
Modulation of infection and type 1 cytokine expression parameters by morphine during in vitro coinfection with human T-cell leukemia virus type I and HIV-1.
Journal of acquired immune deficiency syndromes (1999) 2003;32(4):406-16.
2003: Karuppiah Muthumani; Mark Bagarazzi; Dan Conway; Daniel S Hwang; Kelledy Manson; Richard B Ciccarelli; Zimmra Israel; David C Montefiori; Kenneth Ugen; Nancy Miller; Jong Kim; Jean Boyer; David B Weiner
A Gag-Pol/Env-Rev SIV239 DNA vaccine improves CD4 counts, and reduce viral loads after pathogenic intrarectal SIV(mac)251 challenge in rhesus Macaques.
Vaccine 2003;21(7-8):629-37.
2002: Rob Roy MacGregor; Richard S Ginsberg; Kenneth Ugen; Yaela Baine; Christina U Kang; Xin M Tu; Terry Higgins; David B Weiner; Jean D Boyer
T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev.
AIDS (London, England) 2002;16(16):2137-43.
2002: Victor Raul Gómez-Román; Chuanhai Cao; Yun Bai; Hugo Santamaría; Gonzalo Acero; Karen Manoutcharian; David B Weiner; Kenneth Ugen; Goar Gevorkian
Phage-displayed mimotopes recognizing a biologically active anti-HIV-1 gp120 murine monoclonal antibody.
Journal of acquired immune deficiency syndromes (1999) 2002;31(2):147-53.
2002: Rebecca L Edgeworth; Juan Homero San; Jason A Rosenzweig; Nang L Nguyen; Jean D Boyer; Kenneth Ugen
Vaccine development against HIV-1: current perspectives and future directions.
Immunologic research 2002;25(1):53-74.
2001: Donna Wilcock; Marcia N Gordon; Kenneth Ugen; Paul Gottschall; Giovanni DiCarlo; Chad A Dickey; Kristal W Boyett; Paul T Jantzen; Karen E Connor; J Melachrino; John Hardy; Dave Morgan
Number of Abeta inoculations in APP+PS1 transgenic mice influences antibody titers, microglial activation, and congophilic plaque levels.
DNA and cell biology 2001;20(11):731-6.
2001: Chad A Dickey; Dave Morgan; Sagar Kudchodkar; David B Weiner; Y Bai; C Cao; Marcia N Gordon; Kenneth Ugen
Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1-42 peptide.
DNA and cell biology 2001;20(11):723-9.
2001: Kenneth Ugen; Dave Morgan
Alzheimer's disease: molecularly based immunotherapeutics.
DNA and cell biology 2001;20(11):677-8.
2001: Thomas K Han; S Yoder; C Cao; Kenneth Ugen; My Lien Dao
Expression of Streptococcus mutans wall-associated protein A gene in Chinese hamster ovary cells: prospect for a dental caries DNA vaccine.
DNA and cell biology 2001;20(9):595-601.
2001: Joseph J Kim; Joo-Sung Yang; LK Nottingham; DJ Lee; M Lee; Kelledy Manson; Michael S Wyand; Jean D Boyer; Kenneth Ugen; David B Weiner
Protection from immunodeficiency virus challenges in rhesus macaques by multicomponent DNA immunization.
Virology 2001;285(2):204-17.
2001: Susan B Nyland; SC Specter; Kenneth Ugen
Direct vs. indirect modulation of complex in vitro human retroviral infections by morphine.
Advances in experimental medicine and biology 2001;493():49-58.
2000: Dave Morgan; David M Diamond; Paul Gottschall; Kenneth Ugen; Chad A Dickey; John Hardy; karen duff; Paul T Jantzen; Giovanni DiCarlo; Donna Wilcock; K Connor; Jaime M Hatcher; CE Hope; Marcia N Gordon; Gary W Arendash
A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
Nature 2000;408(6815):982-5.
2000: Jean D Boyer; AD Cohen; Kenneth Ugen; Rebecca L Edgeworth; M Bennett; A Shah; KE Schumann; BM Nath; A Javadian; Mark Bagarazzi; Jong Kim; David B Weiner
Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.
AIDS (London, England) 2000;14(11):1515-22.
2000: S Yoder; C Cao; Kenneth Ugen; My Lien Dao
High-level expression of a truncated wall-associated protein A from the dental cariogenic Streptococcus mutans.
DNA and cell biology 2000;19(7):401-8.
2000: Monica Viveros; Chad A Dickey; Joseph Cotropia; Goar Gevorkian; Carlos Larralde; K Broliden; M Levi; A Burgess; Chuanhai Cao; D B Weiner; Michael G Agadjanyan; Kenneth Ugen
Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
Virology 2000;270(1):135-45.
2000: Chad A Dickey; U Ziegner; Michael G Agadjanyan; V Srikantan; Yosef Refaeli; A Prabhu; A Sato; William V Williams; David B Weiner; Kenneth Ugen
Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization.
DNA and cell biology 2000;19(4):243-52.
2000: Joseph J Kim; J S Yang; T C VanCott; D J Lee; Kelledy Manson; Michael S Wyand; Jean D Boyer; Kenneth Ugen; David B Weiner
Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants.
Journal of virology 2000;74(7):3427-9.
2000: Rebecca L Edgeworth; Kenneth Ugen
Immunopathological factors for vertical transmission of HIV-1.
Pathobiology : journal of immunopathology, molecular and cellular biology 2000;68(2):53-67.
2000: Jeong-Im Sin; J Kim; Michael Chattergoon; Velpandi Ayyavoo; D McCallus; Kenneth Ugen; Jean D Boyer; David B Weiner
Engineering of DNA vaccines using molecular adjuvant plasmids.
Developments in biologicals 2000;104():187-98.
1999: Jean D Boyer; Jong Kim; Kenneth Ugen; AD Cohen; LH Ahn; KE Schumann; KE Lacy; Mark Bagarazzi; A Javadian; Richard B Ciccarelli; Richard S Ginsberg; Rob Roy MacGregor; David B Weiner
HIV-1 DNA vaccines and chemokines.
Vaccine 1999;17 Suppl 2():S53-64.
1999: Mark Bagarazzi; Jean D Boyer; MA Javadian; Michael Chattergoon; A R Shah; AD Cohen; M K Bennett; Richard B Ciccarelli; Kenneth Ugen; David B Weiner
Systemic and mucosal immunity is elicited after both intramuscular and intravaginal delivery of human immunodeficiency virus type 1 DNA plasmid vaccines to pregnant chimpanzees.
The Journal of infectious diseases 1999;180(4):1351-5.
1999: Joseph J Kim; LK Nottingham; A Tsai; DJ Lee; H C Maguire; J Oh; Tzvete Dentchev; Kelledy Manson; Michael S Wyand; Michael G Agadjanyan; Kenneth Ugen; David B Weiner
Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants.
Journal of medical primatology 1999;28(4-5):214-23.
1999: L C Kang; M J Kerben; Kenneth Ugen; SC Specter
Modulation of ex vivo cytokine production by splenocytes using in vitro combined therapeutics in murine retroviral model.
DNA and cell biology 1999;18(7):585-92.
1999: Susan B Nyland; SC Specter; Kenneth Ugen
Morphine effects on HTLV-I infection in the presence or absence of concurrent HIV-1 infection.
DNA and cell biology 1999;18(4):285-91.
1999: Jean D Boyer; Michael Chattergoon; Kenneth Ugen; A Shah; M Bennett; A Cohen; Susan B Nyland; KE Lacy; Mark Bagarazzi; Terry J Higgins; Yaela Baine; Richard B Ciccarelli; Richard S Ginsberg; Rob Roy MacGregor; David B Weiner
Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial.
Clinical immunology (Orlando, Fla.) 1999;90(1):100-7.
1998: Jeong-Im Sin; Joseph J Kim; Kenneth Ugen; Richard B Ciccarelli; Terry J Higgins; David B Weiner
Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes.
European journal of immunology 1998;28(11):3530-40.
1998: Mark Bagarazzi; Jean D Boyer; Kenneth Ugen; MA Javadian; Michael Chattergoon; A Shah; M Bennett; Richard B Ciccarelli; R Carrano; LR Coney; David B Weiner
Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees.
Vaccine 1998;16(19):1836-41.
1998: Kenneth Ugen; Susan B Nyland; Jean D Boyer; C Vidal; L Lera; S Rasheid; Michael Chattergoon; Mark Bagarazzi; Richard B Ciccarelli; T Higgins; Yaela Baine; Richard S Ginsberg; Rob Roy MacGregor; David B Weiner
DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans.
Vaccine 1998;16(19):1818-21.
1998: Rob Roy MacGregor; Jean D Boyer; Kenneth Ugen; KE Lacy; Stephen J Gluckman; Mark Bagarazzi; Michael Chattergoon; Yaela Baine; Terry J Higgins; Richard B Ciccarelli; LR Coney; Richard S Ginsberg; David B Weiner
First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.
The Journal of infectious diseases 1998;178(1):92-100.
1998: Michael G Agadjanyan; Michael Chattergoon; Irina Petrushina; M Bennett; J Kim; Kenneth Ugen; Thomas Kieber-Emmons; David B Weiner
Monoclonal antibodies define a cellular antigen involved in HTLV-I infection.
Hybridoma 1998;17(1):9-19.
1998: SN Noe; Susan B Nyland; Kenneth Ugen; Herman Friedman; Thomas Klein
Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-1MN.
Advances in experimental medicine and biology 1998;437():223-9.
1998: Susan B Nyland; SC Specter; J Im-Sin; Kenneth Ugen
Opiate effects on in vitro human retroviral infection.
Advances in experimental medicine and biology 1998;437():91-100.
1998: Jean Boyer; Kenneth Ugen; Bin Wang; Michael Chattergoon; A Tsai; MM Merva; David B Weiner
Induction of a TH1 type cellular immune response to the human immunodeficiency type 1 virus by in vivo DNA inoculation.
Developments in biological standardization 1998;92():169-74.
1998: Michael G Agadjanyan; Bin Wang; Susan B Nyland; David B Weiner; Kenneth Ugen
DNA plasmid based vaccination against the oncogenic human T cell leukemia virus type 1.
Current topics in microbiology and immunology 1998;226():175-92.
1997: Michael G Agadjanyan; NN Trivedi; Sagar Kudchodkar; M Bennett; W Levine; A Lin; Jean Boyer; D Levy; Kenneth Ugen; Joseph J Kim; David B Weiner
An HIV type 2 DNA vaccine induces cross-reactive immune responses against HIV type 2 and SIV.
AIDS research and human retroviruses 1997;13(18):1561-72.
1997: Jean D Boyer; Kenneth Ugen; Michael Chattergoon; Bin Wang; A Shah; Michael G Agadjanyan; Mark Bagarazzi; A Javadian; R Carrano; LR Coney; William V Williams; David B Weiner
DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees.
The Journal of infectious diseases 1997;176(6):1501-9.
1997: Kenneth Ugen; Jean D Boyer; Bin Wang; Mark Bagarazzi; A Javadian; patrice frost; MM Merva; Michael G Agadjanyan; Susan B Nyland; William V Williams; LR Coney; Richard B Ciccarelli; David B Weiner
Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial.
Vaccine 1997;15(8):927-30.
1997: Bin Wang; Kesen Dang; Michael G Agadjanyan; V Srikantan; F Li; Kenneth Ugen; Jean Boyer; MM Merva; William V Williams; David B Weiner
Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site.
Vaccine 1997;15(8):821-5.
1997: Jean D Boyer; Kenneth Ugen; Bin Wang; Michael G Agadjanyan; L Gilbert; Mark Bagarazzi; Michael Chattergoon; patrice frost; A Javadian; William V Williams; Yosef Refaeli; Richard B Ciccarelli; D McCallus; LR Coney; David B Weiner
Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.
Nature medicine 1997;3(5):526-32.
1997: Sundarasamy Mahalingam; B MacDonald; Kenneth Ugen; Velpandi Ayyavoo; Michael G Agadjanyan; William V Williams; David B Weiner
In vitro and in vivo tumor growth suppression by HIV-1 Vpr.
DNA and cell biology 1997;16(2):137-43.
1997: Kenneth Ugen; V Srikantan; J J Goedert; R P Nelson; William V Williams; David B Weiner
Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein.
The Journal of infectious diseases 1997;175(1):63-9.
1996: Velpandi Ayyavoo; Kenneth Ugen; L S Fernandes; J J Goedert; Arye Rubinstein; William V Williams; David B Weiner
Analysis of genetic heterogeneity, antigenicity, and biological characteristics of HIV-1 in a maternal transmitter and nontransmitter patient pair.
DNA and cell biology 1996;15(7):571-80.
1996: Joseph Cotropia; Kenneth Ugen; S Kliks; Kristina Broliden; P A Broliden; James A Hoxie; V Srikantan; William V Williams; David B Weiner
A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(3):221-32.
1996: Jean D Boyer; Bin Wang; Kenneth Ugen; Michael G Agadjanyan; A Javadian; patrice frost; Kesen Dang; R A Carrano; Richard B Ciccarelli; LR Coney; William V Williams; David B Weiner
In vivo protective anti-HIV immune responses in non-human primates through DNA immunization.
Journal of medical primatology 1996;25(3):242-50.
1995: Kenneth Ugen
Vertical transmission of HIV-1 infection. Diagnosis and prevention.
The Journal of the Florida Medical Association 1995;82(12):825-6.
1995: Bin Wang; Jean Boyer; V Srikantan; Kenneth Ugen; M Agadjanian; M Merva; L Gilbert; Kesen Dang; D McCallus; K Moelling
DNA inoculation induces cross clade anti-HIV-1 responses.
Annals of the New York Academy of Sciences 1995;772():186-97.
1995: Bin Wang; Jean Boyer; V Srikantan; Kenneth Ugen; L Gilbert; C Phan; Kesen Dang; M Merva; Michael G Agadjanyan; M Newman
Induction of humoral and cellular immune responses to the human immunodeficiency type 1 virus in nonhuman primates by in vivo DNA inoculation.
Virology 1995;211(1):102-12.
1995: Bin Wang; M Merva; Kesen Dang; Kenneth Ugen; William V Williams; David B Weiner
Immunization by direct DNA inoculation induces rejection of tumor cell challenge.
Human gene therapy 1995;6(4):407-18.
1995: Bin Wang; Jean D Boyer; Kenneth Ugen; V Srikantan; V Ayyaroo; Michael G Agadjanyan; William V Williams; M Newman; LR Coney; R Carrano
Nucleic acid-based immunization against HIV-I: induction of protective in vivo immune responses.
AIDS (London, England) 1995;9 Suppl A():S159-70.
1994: LR Coney; Bin Wang; Kenneth Ugen; Jean Boyer; D McCallus; V Srikantan; Michael G Agadjanyan; Catherine J Pachuk; K Herold; M Merva
Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo.
Vaccine 1994;12(16):1545-50.
1994: V Srikantan; Bin Wang; M A Satre; Kenneth Ugen; Kesen Dang; F Scales; A P Godillot; William V Williams; David B Weiner
Cloning and biological characterization of human single-chain Fv fragments that mediate neutralization of HIV-1.
AIDS (London, England) 1994;8(11):1525-32.
1994: M D'Angelo; J M Chen; Kenneth Ugen; Robert Greene
TGF beta 1 regulation of collagen metabolism by embryonic palate mesenchymal cells.
The Journal of experimental zoology 1994;270(2):189-201.
1994: William V Williams; J M VonFeldt; H Rosenbaum; Kenneth Ugen; David B Weiner
Molecular cloning of a soluble form of the granulocyte-macrophage colony-stimulating factor receptor alpha chain from a myelomonocytic cell line. Expression, biologic activity, and preliminary analysis of transcript distribution.
Arthritis and rheumatism 1994;37(10):1468-78.
1994: A I Sato; F B Balamuth; Kenneth Ugen; William V Williams; David B Weiner
Identification of CD7 glycoprotein as an accessory molecule in HIV-1-mediated syncytium formation and cellfree infection.
Journal of immunology (Baltimore, Md. : 1950) 1994;152(10):5142-52.
1994: Dianne Robert Soprano; M Gyda; H Jiang; D C Harnish; Kenneth Ugen; M Satre; L Chen; Kenneth J Soprano; Devendra M Kochhar
A sustained elevation in retinoic acid receptor-beta 2 mRNA and protein occurs during retinoic acid-induced fetal dysmorphogenesis.
Mechanisms of development 1994;45(3):243-53.
1994: Michael G Agadjanyan; Kenneth Ugen; Bin Wang; William V Williams; David B Weiner
Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection.
Journal of virology 1994;68(1):485-93.
1994: Bin Wang; M Merva; Kesen Dang; Kenneth Ugen; Jean Boyer; William V Williams; David B Weiner
DNA inoculation induces protective in vivo immune responses against cellular challenge with HIV-1 antigen-expressing cells.
AIDS research and human retroviruses 1994;10 Suppl 2():S35-41.
1994: Kenneth Ugen; J M Von Feldt; David B Weiner; U H Ziegner
Diagnosis and prediction of pediatric HIV-1 infection and AIDS: current status.
Journal of clinical laboratory analysis 1994;8(5):309-14.
1994: Kenneth Ugen; Bin Wang; Velpandi Ayyavoo; Michael G Agadjanyan; Jean Boyer; F Li; Sagar Kudchodkar; J Lin; M Merva; L Fernandes
DNA inoculation as a novel vaccination method against human retroviruses with rheumatic disease associations.
Immunologic research 1994;13(2-3):154-62.
1994: K V Prammer; J Boyer; Kenneth Ugen; S J Shattil; Thomas Kieber-Emmons
Bioactive Arg-Gly-Asp conformations in anti-integrin GPIIb-IIIa antibodies.
Receptor 1994;4(2):93-108.
1994: A M Eaton; Kenneth Ugen; D B Weiner; T Wildes; Jay A Levy
An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement.
AIDS research and human retroviruses 1994;10(1):13-8.
1993: Bin Wang; Michael G Agadjanyan; V Srikantan; Kenneth Ugen; W Hall; Mark H Kaplan; Kesen Dang; William V Williams; David B Weiner
Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.
AIDS research and human retroviruses 1993;9(9):849-60.
1993: Bin Wang; Kenneth Ugen; V Srikantan; Michael G Agadjanyan; Kesen Dang; Yosef Refaeli; A I Sato; Jean Boyer; William V Williams; David B Weiner
Gene inoculation generates immune responses against human immunodeficiency virus type 1.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(9):4156-60.
1993: S Bhat; R V Mettus; E P Reddy; Kenneth Ugen; V Srikanthan; William V Williams; David B Weiner
The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275.
AIDS research and human retroviruses 1993;9(2):175-81.
1992: K Osther; A Wiik; F Black; P Skinhøj; G Kellermann; Kenneth Ugen; W V Williams; D B Weiner
PASSHIV-1 treatment of patients with HIV-1 infection. A preliminary report of a phase I trial of hyperimmune porcine immunoglobulin to HIV-1.
AIDS (London, England) 1992;6(12):1457-64.
1992: Kenneth Ugen; James J Goedert; Jean Boyer; Yosef Refaeli; I Frank; William V Williams; A Willoughby; S Landesman; Hermann Mendez; Arye Rubinstein
Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1.
The Journal of clinical investigation 1992;89(6):1923-30.
1992: Ilona Laczkó; Miklós Hollósi; L Urge; Kenneth Ugen; D B Weiner; Henry H Mantsch; J Thurin; László Otvös
Synthesis and conformational studies of N-glycosylated analogues of the HIV-1 principal neutralizing determinant.
Biochemistry 1992;31(17):4282-8.
1992: M A Satre; Kenneth Ugen; Devendra M Kochhar
Developmental changes in endogenous retinoids during pregnancy and embryogenesis in the mouse.
Biology of reproduction 1992;46(5):802-10.
1992: J M Von Feldt; Thomas Kieber-Emmons; David B Weiner; Kenneth Ugen; William V Williams
Molecular structure and granulocyte/macrophage colony-stimulating factor activity.
DNA and cell biology 1992;11(3):183-91.
1992: Kenneth Ugen; D McCallus; J M Von Feldt; William V Williams; M I Greene; David B Weiner
Ocular tissue involvement in HIV infection: immunological and pathological aspects.
Immunologic research 1992;11(2):141-53.
1992: Thomas Kieber-Emmons; JF Krowka; Jean Boyer; Kenneth Ugen; William V Williams; W J Morrow; David B Weiner
Immunological characteristics of the putative CD4-binding site of the HIV-1 envelope protein.
Pathobiology : journal of immunopathology, molecular and cellular biology 1992;60(4):187-94.
1992: D McCallus; Kenneth Ugen; A I Sato; William V Williams; David B Weiner
Construction of a recombinant bacterial human CD4 expression system producing a bioactive CD4 molecule.
Viral immunology 1992;5(2):163-72.
1991: K Osther; G Kellermann; Kenneth Ugen; W V Williams; D B Weiner
Protective humoral immune responses to the human immunodeficiency virus induced in immunized pigs: a possible source of therapeutic immunoglobulin preparations.
Hybridoma 1991;10(6):673-83.
1988: Kenneth Ugen; M Mahalingam; Paul A Klein; K J Kao
Inhibition of tumor cell-induced platelet aggregation and experimental tumor metastasis by the synthetic Gly-Arg-Gly-Asp-Ser peptide.
Journal of the National Cancer Institute 1988;80(18):1461-6.
1988: M Mahalingam; Kenneth Ugen; K J Kao; Paul A Klein
Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants.
Cancer research 1988;48(6):1460-4.
1987: Kenneth Ugen; William J Scott
Reduction of uterine blood flow by phenylephrine, an alpha-adrenergic agonist, in the day 11 pregnant rat: relationship to potentiation of acetazolamide teratogenesis.
Teratology 1987;36(1):133-41.
1986: Kenneth Ugen; W J Scott
Acetazolamide teratogenesis in Wistar rats: potentiation and antagonism by adrenergic agents.
Teratology 1986;34(2):195-200.
1985: Kenneth Ugen; W J Scott
Potentiation of acetazolamide induced ectrodactyly in Wistar rats by vasoactive agents and physical clamping of the uterus.
Teratology 1985;31(2):273-8.
1980: Chien Ho; Y Giza; S Takahashi; Kenneth Ugen; P F Cottam; S R Dowd
A proton nuclear magnetic resonance investigation of histidine-binding protein J of Salmonella typhimurium: a model for transport of L-histidine across cytoplasmic membrane.
Journal of supramolecular structure 1980;13(2):131-45.